2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Joong Won Park, June Sung Lee, Kyung Suk Suh, Jin Wook Chung, Jinsil Seong, Do Young Kim, Ji Hoon Kim, Hyeong Jun Kim, Hwi Young Kim, Soo Young Park, Joo Hyeon Shim, Jeong Hoon Lee, Young Suk Lim, Ho Yeong Lim, Jeong Won Jang, Jae Young Jang, Dae Won Jeon, Yang Seok Ko, Kyung Sik Kim, Dong Sik KimSeong Hoon Kim, Jong Man Kim, Yeong Cheol Yun, Dong Hwan Jeong, Jai Young Cho, Young Hwan Koh, Kyeong Min Kim, So Yeon Kim, Young Hwan Kim, In Joon Lee, Jeong Min Lee, Hyeon Cheol Lim, Sung Ki Cho, Ho Jong Cheon, Jun Il Choi, Chul Seung Kay, Mi Sook Kim, Tae Hyun Kim, Hee Chul Park, Sun Hyeon Bae, Sang Min Yoon, Won Sup Yoon, Won Il Jang

    Research output: Contribution to journalReview articlepeer-review

    112 Citations (Scopus)

    Abstract

    Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection is high in middle-aged and elderly patients. These practice guidelines will provide useful and constructive advice for the clinical management of patients with HCC. A total of 44 experts in hepatology, oncology, surgery, radiology and radiation oncology in the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2014 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions.

    Original languageEnglish
    Pages (from-to)227-299
    Number of pages73
    JournalGut and liver
    Volume13
    Issue number3
    DOIs
    Publication statusPublished - 2019

    Keywords

    • Carcinoma, hepatocellular
    • Diagnosis
    • Guidelines
    • Management

    ASJC Scopus subject areas

    • Hepatology
    • Gastroenterology

    Fingerprint

    Dive into the research topics of '2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma'. Together they form a unique fingerprint.

    Cite this